Revium Rx (RVRC) Assets (2024 - 2025)

Revium Rx (RVRC) reported Assets of $8.3 million for Q4 2025, down 59.1% on a YoY basis from $20.3 million in Q4 2024, and down 59.1% sequentially from $20.3 million in Q4 2024.

Revium Rx (RVRC) Assets (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Assets data on file, last reported at $8.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 59.1% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2025 stood at $8.3 million (down 59.1% YoY), and the FY2025 full-year result was $8.3 million, down 59.1% from the prior year.
  • Assets retreated to $8.3 million in Q4 2025, from $20.3 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $20.3 million in Q4 2024 to a low of $8.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Veeva Systems 31.70 Bn 24.39 Bn 662.02 Mn 9.13 Bn
2 BrightSpring Health Services 14.70 Bn 13.80 Bn 482.22 Mn 6.21 Bn
3 Healthequity 8.30 Bn 8.04 Bn 256.31 Mn 3.31 Bn
4 Hinge Health 5.94 Bn 5.62 Bn 154.23 Mn 728.77 Mn
5 10x Genomics 5.86 Bn 5.32 Bn 106.18 Mn 1.02 Bn
6 MiniMed 4.47 Bn 4.17 Bn 480.00 Mn 4.63 Bn
7 Waystar Holding 4.45 Bn 4.39 Bn 216.84 Mn 5.84 Bn
8 Doximity 3.94 Bn 3.19 Bn 125.97 Mn 1.12 Bn
9 Privia Health 3.18 Bn 2.76 Bn - 1.42 Bn
10 Revium Rx 101.42 Mn 98.71 Mn - 8.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.30 Mn
Dec 31, 2024 20.28 Mn